Kate Lapane to Hypoglycemic Agents
This is a "connection" page, showing publications Kate Lapane has written about Hypoglycemic Agents.
Connection Strength
1.253
-
Rajpathak SN, Fu C, Brodovicz KG, Engel SS, Lapane K. Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes. Drugs Aging. 2015 Apr; 32(4):321-7.
Score: 0.417
-
Dore DD, Trivedi AN, Mor V, Lapane KL. Association between extent of thiazolidinedione exposure and risk of acute myocardial infarction. Pharmacotherapy. 2009 Jul; 29(7):775-83.
Score: 0.280
-
Allsworth JE, Toppa R, Palin NC, Lapane KL. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents. Ethn Dis. 2005; 15(2):205-12.
Score: 0.205
-
Allsworth JE, Toppa R, Palin NC, Lapane KL. For the patient. Many nursing home patients do not receive diabetes medicine. Ethn Dis. 2005; 15(2):351.
Score: 0.205
-
Lapane KL, Jesdale BM, Dub? CE, Pimentel CB, Rajpathak SN. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2015 Aug; 109(2):411-9.
Score: 0.105
-
Spooner JJ, Lapane KL, Hume AL, Mor V, Gambassi G. Pharmacologic treatment of diabetes in long-term care. J Clin Epidemiol. 2001 May; 54(5):525-30.
Score: 0.040